POZ - News : Virtual Human Body in HIV Drug Simulation
Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » News » January 2008

Web Exclusives

Evaluating the Costs of Earlier HIV Treatment

HIV Prevention Gets “Fergalicious”

Changing the HIV Treatment Paradigm

» More

Most Talked About

Magic Johnson Accused of Faking HIV (41)

The POZ/DDF Ratio (blog) (30)

Guidelines Prediction: Start Treatment Earlier (blog) (16)

HIV-Positive People Living Longer Than Ever Before (14)

Bone Marrow Transplant: Potential AIDS Cure? (8)

Obama Campaign Set to Boost Domestic HIV/AIDS Funding (8)

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Herpes Simplex Virus

Human Papilloma Virus (HPV)

Shingles

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

10 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

January 30, 2008

Virtual Human Body in HIV Drug Simulation

Scientists at University College London have successfully utilized the national computing grids of the United States and the United Kingdom to create a Virtual Physiological Human simulation, essentially using supercomputers to simulate the inner workings of the human body. It may one day help people living with HIV better cope with drug resistance, ScienceDaily reports (sciencedaily.com, 1/29).

Using the amount of computational power necessary to perform long-range weather forecasts, scientists were able to predict how the antiretroviral drug saquinavir would work in the body. In simulating the human body’s reaction to the drug through this massive computer network, scientists are better able to examine phenomena at the organ, tissue, cell and molecular level.

According to ScienceDaily, the goal of this study is to eliminate “trial and error” prescriptions. However, researchers such as head study author Professor Peter Coveney at the UCL Department of Chemistry are concerned that running such simulations for individual patients may prove costly.

“We have some difficult questions ahead of us, such as how much of our computing resources could be devoted to helping patients and at what price,” says Coveney. “At present, such simulations—requiring a substantial amount of computing power—might prove costly for the National Health Service, but technological advances and those in the economics of computing would bring costs down.”


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

         


[Go to top]


Get Started
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Talk to Us
Weekly Poll
Question: Would legalizing prostitution reduce the spread of HIV?
Yes
No
I don't know.

Monthly Poll
Question: Do you believe that prisoners receive adequate health care?
Yes
No
I don't know.

Surveys
Tell us when and to whom you disclose your status.

Tell us about your travel experiences.

more surveys
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy